SNP chromosome microarray genotyping for detection of uniparental disomy in the clinical diagnostic laboratory.

Autor: Ngo C; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia. Electronic address: con.ngo@health.nsw.gov.au., Baluyot M; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Bennetts B; Specialty of Genomic Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Sydney Genome Diagnostics, Molecular Genetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Carmichael J; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Clark A; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Darmanian A; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Gayagay T; Sydney Genome Diagnostics, Molecular Genetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Jones L; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Nash B; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia; Specialty of Genomic Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Clark M; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Jose N; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., Robinson S; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia., St Heaps L; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia; Specialty of Genomic Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Wright D; Sydney Genome Diagnostics, Cytogenetics, The Children's Hospital at Westmead, Westmead, NSW, Australia; Specialty of Genomic Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Jazyk: angličtina
Zdroj: Pathology [Pathology] 2023 Oct; Vol. 55 (6), pp. 818-826. Date of Electronic Publication: 2023 Jun 16.
DOI: 10.1016/j.pathol.2023.04.004
Abstrakt: Single nucleotide polymorphism (SNP) chromosome microarray is well established for investigation of children with intellectual deficit/development delay and prenatal diagnosis of fetal malformation but has also emerged for uniparental disomy (UPD) genotyping. Despite published guidelines on clinical indications for testing there are no laboratory guidelines published for performing SNP microarray UPD genotyping. We evaluated SNP microarray UPD genotyping using Illumina beadchips on family trios/duos within a clinical cohort (n=98) and then explored our findings in a post-study audit (n=123). UPD occurred in 18.6% and 19.5% cases, respectively, with chromosome 15 most frequent (62.5% and 25.0%). UPD was predominantly maternal in origin (87.5% and 79.2%), highest in suspected genomic imprinting disorder cases (56.3% and 41.7%) but absent amongst children of translocation carriers. We assessed regions of homozygosity among UPD cases. The smallest interstitial and terminal regions were 2.5 Mb and 9.3 Mb, respectively. We found regions of homozygosity confounded genotyping in a consanguineous case with UPD15 and another with segmental UPD due to non-informative probes. In a unique case with chromosome 15q UPD mosaicism, we established the detection limit of mosaicism as ∼5%. From the benefits and pitfalls identified in this study, we propose a testing model and recommendations for UPD genotyping by SNP microarray.
(Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: